Additional information Active substance Semaglutide Chemical name Semaglutide Side effects Nausea, vomiting, diarrhea, abdominal pain, decreased appetite Effects Improved glycemic control, weight loss Dosage (sports) Not recommended for use in sports Dosage (medical) 0.25 mg once weekly, increasing to 0.5 mg and up to 1 mg as tolerated and needed Half-life Approximately 1 week Main action Lowers blood glucose levels Substance class GLP-1 receptor agonist Formula C187H291N45O59 Storage conditions Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) FORM 3 pre-filled pen x 3 ml x 1.34mg/ml Trade name Ozempic, Rybelsus Blood pressure Can cause a reduction in blood pressure Also known as N/A Lab Test Blood glucose levels, HbA1c Hepatotoxicity Low risk Water Retention Minimal Dosage 0.25-0.5 mg/week Use in sports None, not indicated for performance enhancement Manufacturer Novo Nordisk